Bomedemstat and Maintenance Immunotherapy for Treatment of Newly Diagnosed Extensive Stage Small Cell Lung Cancer

Clinical trial NCT05191797 · TERMINATED

Trial details

NCT number: NCT05191797
Sponsor: University of Washington
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Extensive Stage Lung Small Cell Carcinoma Limited Stage Lung Small Cell Carcinoma

Start date: 2022-04-11
Primary completion: 2023-08-03
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.